Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: After-Hours Movers » 19:09
06/30/20
06/30
19:09
06/30/20
19:09
FDX

FedEx

$140.25 /

+5.86 (+4.36%)

, CDMO

Avid Bioservices

$6.56 /

+0.35 (+5.64%)

, TTOO

T2 Biosystems

$1.27 /

-0.03 (-2.31%)

, AKRO

Akero Therapeutics

$24.85 /

+1.91 (+8.33%)

, DKNG

DraftKings

$33.27 /

-0.295 (-0.88%)

, SCS

Steelcase

$12.07 /

-0.135 (-1.11%)

, DENN

Denny's

$10.10 /

-0.13 (-1.27%)

, GSX

GSX Techedu

$60.01 /

+1.725 (+2.96%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

GSX GSX Techedu
$60.01 /

+1.725 (+2.96%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DKNG DraftKings
$33.27 /

-0.295 (-0.88%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

CDMO Avid Bioservices
$6.56 /

+0.35 (+5.64%)

AKRO Akero Therapeutics
$24.85 /

+1.91 (+8.33%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

06/24/20 JPMorgan
FedEx price target raised to $145 from $115 at JPMorgan
06/24/20 UBS
FedEx price target raised to $158 from $135 at UBS
06/22/20 BMO Capital
FedEx price target raised to $130 from $115 at BMO Capital
06/19/20 Credit Suisse
FedEx price target raised to $150 from $121 at Credit Suisse
CDMO Avid Bioservices
$6.56 /

+0.35 (+5.64%)

12/10/19 First Analysis
Avid Bioservices upgraded to Strong Buy from Outperform at First Analysis
10/16/19 Stephens
Avid Bioservices initiated with an Overweight at Stephens
10/16/19
Craig-Hallum bullish on Avid Bioservices, initiates with a Buy
10/16/19 Craig-Hallum
Avid Bioservices initiated with a Buy at Craig-Hallum
TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

02/06/20 JonesTrading
T2 Biosystems upgraded to Buy from Hold at JonesTrading
01/23/20 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
11/26/19 Janney Montgomery Scott
T2 Biosystems downgraded to Neutral at Janney Montgomery Scott
11/26/19 Janney Montgomery Scott
T2 Biosystems downgraded to Neutral from Buy at Janney Montgomery Scott
AKRO Akero Therapeutics
$24.85 /

+1.91 (+8.33%)

03/31/20 H.C. Wainwright
Akero's BALANCED study results 'quite impressive,' says H.C. Wainwright
03/02/20 H.C. Wainwright
Akero Therapeutics initiated with a Buy at H.C. Wainwright
02/13/20 Roth Capital
Akero Therapeutics price target raised to $43 from $34 at Roth Capital
02/10/20 Canaccord
Akero Therapeutics initiated with a Buy at Canaccord
DKNG DraftKings
$33.27 /

-0.295 (-0.88%)

06/30/20 Stephens
Stephens starts DraftKings at Overweight amid U.S. gambling 'mega-trend'
06/30/20 Stephens
DraftKings initiated with an Overweight at Stephens
06/26/20
Fly Intel: Top five analyst initiations
06/25/20 Rosenblatt
DraftKings initiated with a Buy at Rosenblatt
SCS Steelcase
$12.07 /

-0.135 (-1.11%)

05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
10/07/19 Raymond James
Raymond James steps away from three office furniture stocks
10/07/19 Raymond James
Steelcase downgraded to Market Perform from Strong Buy at Raymond James
09/23/19 Raymond James
Steelcase price target raised to $23 from $21 at Raymond James
DENN Denny's
$10.10 /

-0.13 (-1.27%)

06/17/20 SunTrust
Denny's price target raised to $15 from $12 at SunTrust
05/15/20 Stephens
Stephens reiterates Overweight rating on Denny's after Q1 report
04/08/20 Oppenheimer
Denny's price target lowered to $13 from $27 at Oppenheimer
04/01/20 SunTrust
El Pollo Loco upgraded to Buy from Hold at SunTrust
GSX GSX Techedu
$60.01 /

+1.725 (+2.96%)

06/30/20 Goldman Sachs
GSX Techedu downgraded to Neutral following outperformance at Goldman Sachs
06/30/20 Goldman Sachs
GSX Techedu downgraded to Neutral from Buy at Goldman Sachs
05/11/20 Barclays
GSX Techedu offered comprehensive rebuttal to short sellers, says Barclays
05/11/20 Nomura Instinet
GSX Techedu price target raised to $40 from $35 at Nomura Instinet
TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

GSX GSX Techedu
$60.01 /

+1.725 (+2.96%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DKNG DraftKings
$33.27 /

-0.295 (-0.88%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

CDMO Avid Bioservices
$6.56 /

+0.35 (+5.64%)

AKRO Akero Therapeutics
$24.85 /

+1.91 (+8.33%)

  • 01
    Jul
  • 19
    Jun
  • 21
    Nov
GSX GSX Techedu
$60.01 /

+1.725 (+2.96%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DKNG DraftKings
$33.27 /

-0.295 (-0.88%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

GSX GSX Techedu
$60.01 /

+1.725 (+2.96%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DKNG DraftKings
$33.27 /

-0.295 (-0.88%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

CDMO Avid Bioservices
$6.56 /

+0.35 (+5.64%)

AKRO Akero Therapeutics
$24.85 /

+1.91 (+8.33%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

GSX GSX Techedu
$60.01 /

+1.725 (+2.96%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DKNG DraftKings
$33.27 /

-0.295 (-0.88%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

CDMO Avid Bioservices
$6.56 /

+0.35 (+5.64%)

AKRO Akero Therapeutics
$24.85 /

+1.91 (+8.33%)

Earnings
Avid Bioservices reports Q4 EPS (11c), consensus (16) » 16:09
06/30/20
06/30
16:09
06/30/20
16:09
CDMO

Avid Bioservices

$6.61 /

+0.4 (+6.44%)

Reports Q4 revenue…

Reports Q4 revenue $12.6M, consensus $8.5M. As of April 30, 2020, revenue backlog was $65 million, an increase of 12% compared to $58 million at the end of the third quarter of fiscal 2020, and an increase of 41% compared to $46 million at the end of last fiscal year. The company expects to recognize the majority of this backlog during fiscal 2021.

ShowHide Related Items >><<
CDMO Avid Bioservices
$6.61 /

+0.4 (+6.44%)

CDMO Avid Bioservices
$6.61 /

+0.4 (+6.44%)

12/10/19 First Analysis
Avid Bioservices upgraded to Strong Buy from Outperform at First Analysis
10/16/19 Stephens
Avid Bioservices initiated with an Overweight at Stephens
10/16/19
Craig-Hallum bullish on Avid Bioservices, initiates with a Buy
10/16/19 Craig-Hallum
Avid Bioservices initiated with a Buy at Craig-Hallum
CDMO Avid Bioservices
$6.61 /

+0.4 (+6.44%)

CDMO Avid Bioservices
$6.61 /

+0.4 (+6.44%)

CDMO Avid Bioservices
$6.61 /

+0.4 (+6.44%)

Options
Avid Bioservices options imply 50.7% move in share price post-earnings » 15:34
06/30/20
06/30
15:34
06/30/20
15:34
CDMO

Avid Bioservices

$6.70 /

+0.49 (+7.89%)

Pre-earnings options…

Pre-earnings options volume in Avid Bioservices is 9.8x normal with calls leading puts 8:5. Implied volatility suggests the market is anticipating a move near 50.7%, or $3.35, after results are released. Median move over the past eight quarters is 19.8%.

ShowHide Related Items >><<
CDMO Avid Bioservices
$6.70 /

+0.49 (+7.89%)

CDMO Avid Bioservices
$6.70 /

+0.49 (+7.89%)

12/10/19 First Analysis
Avid Bioservices upgraded to Strong Buy from Outperform at First Analysis
10/16/19 Stephens
Avid Bioservices initiated with an Overweight at Stephens
10/16/19
Craig-Hallum bullish on Avid Bioservices, initiates with a Buy
10/16/19 Craig-Hallum
Avid Bioservices initiated with a Buy at Craig-Hallum
CDMO Avid Bioservices
$6.70 /

+0.49 (+7.89%)

CDMO Avid Bioservices
$6.70 /

+0.49 (+7.89%)

Over a week ago
Hot Stocks
Avid Bioservices appoints Nicholas Green as president, CEO » 08:06
06/23/20
06/23
08:06
06/23/20
08:06
CDMO

Avid Bioservices

$5.62 /

+0.02 (+0.36%)

Avid Bioservices…

Avid Bioservices announced that Nicholas Green has been appointed president and CEO, as well as a member of the company's board of directors, effective July 30, 2020. He will succeed Rick Hancock who has served as interim president and CEO since May 2019. Mr. Hancock will continue to serve on Avid's board of directors. Green most recently served as president and CEO of Therapure Biopharma, a Canada-based biopharmaceutical company which includes Therapure Biomanufacturing.

ShowHide Related Items >><<
CDMO Avid Bioservices
$5.62 /

+0.02 (+0.36%)

CDMO Avid Bioservices
$5.62 /

+0.02 (+0.36%)

12/10/19 First Analysis
Avid Bioservices upgraded to Strong Buy from Outperform at First Analysis
10/16/19 Stephens
Avid Bioservices initiated with an Overweight at Stephens
10/16/19
Craig-Hallum bullish on Avid Bioservices, initiates with a Buy
10/16/19 Craig-Hallum
Avid Bioservices initiated with a Buy at Craig-Hallum
CDMO Avid Bioservices
$5.62 /

+0.02 (+0.36%)

CDMO Avid Bioservices
$5.62 /

+0.02 (+0.36%)

Over a month ago
Hot Stocks
Avid Bioservices, Aragen Bioscience enter agreement for integrated solution » 08:55
05/06/20
05/06
08:55
05/06/20
08:55
CDMO

Avid Bioservices

$6.04 /

-0.39 (-6.07%)

Avid Bioservices and…

Avid Bioservices and Aragen Bioscience announced a co-marketing agreement that will provide clients an integrated "sequence-to-manufacturing" service. Under terms of the non-exclusive agreement, the companies will offer customers Aragen's cell line development expertise integrated with Avid's upstream and downstream process development and analytical services to drive efficiencies and reduce overall timelines for delivering CGMP bulk drug substances.

ShowHide Related Items >><<
CDMO Avid Bioservices
$6.04 /

-0.39 (-6.07%)

12/10/19 First Analysis
Avid Bioservices upgraded to Strong Buy from Outperform at First Analysis
10/16/19 Stephens
Avid Bioservices initiated with an Overweight at Stephens
10/16/19
Craig-Hallum bullish on Avid Bioservices, initiates with a Buy
10/16/19 Craig-Hallum
Avid Bioservices initiated with a Buy at Craig-Hallum
Over a quarter ago
On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 16:40
03/11/20
03/11
16:40
03/11/20
16:40
PEP

PepsiCo

$129.66 /

-4.57 (-3.40%)

, MNST

Monster Beverage

$61.86 /

-4.18 (-6.33%)

, KO

Coca-Cola

$52.21 /

-1.44 (-2.68%)

, DXC

DXC Technology

$16.42 /

+0.01 (+0.06%)

, BA

Boeing

$188.70 /

-42.42 (-18.35%)

, ACDVF

Air Canada

$0.00 /

+ (+0.00%)

, ADDYY

Adidas

$0.00 /

+ (+0.00%)

, TMUS

T-Mobile

$86.49 /

+1.51 (+1.78%)

, S

Sprint

$8.85 /

+0.27 (+3.15%)

, EBAY

eBay

$34.85 /

-1.18 (-3.28%)

, VIR

Vir Biotechnology

$33.38 /

+3.43 (+11.45%)

, MNK

Mallinckrodt

$3.05 /

+0.855 (+39.04%)

, MTDR

Matador

$1.98 /

-0.39 (-16.46%)

, CDMO

Avid Bioservices

$4.51 /

-1.5 (-24.96%)

After seeing a bounce…

Open Full Text

ShowHide Related Items >><<
PEP PepsiCo
$129.66 /

-4.57 (-3.40%)

03/11/20 Stifel
Pepsi deal potentially increases odds of Coke acquiring Monster, says Stifel
02/14/20 SunTrust
PepsiCo price target raised to $135 from $125 at SunTrust
02/14/20 Guggenheim
Pepsi guidance may be 'slightly disappointing' compared to Coke, says Guggenheim
01/02/20 Cantor Fitzgerald
Cantor says time for Peltz to call on Aurora to show financial discipline
MNST Monster Beverage
$61.86 /

-4.18 (-6.33%)

02/28/20 Morgan Stanley
Morgan Stanley expects positive stock reaction to Monster Beverage beat
02/23/20 Stifel
Monster Beverage price target raised to $78 from $71 at Stifel
02/03/20 Morgan Stanley
Monster Beverage upgraded to Overweight, price target to $78 at Morgan Stanley
KO Coca-Cola
$52.21 /

-1.44 (-2.68%)

01/31/20 RBC Capital
Coca-Cola price target raised to $66 from $60 at RBC Capital
01/31/20 SunTrust
Coca-Cola price target raised to $65 from $60 at SunTrust
DXC DXC Technology
$16.42 /

+0.01 (+0.06%)

03/11/20 Wells Fargo
DXC Technology price target lowered to $18 from $36 at Wells Fargo
03/11/20 Citi
DXC Technology divestiture proceeds higher than expected, says Citi
02/26/20 Morgan Stanley
DXC Technology resumed with an Overweight at Morgan Stanley
01/09/20 Wells Fargo
Wells Fargo changes three ratings in Commercial IT Services heading into 2020
BA Boeing
$188.70 /

-42.42 (-18.35%)

03/11/20 Argus
United Airlines downgraded to Hold from Buy at Argus
03/11/20 Goldman Sachs
Goldman cuts targets across Aerospace coverage for COVID-19 impact
03/11/20 Goldman Sachs
Spirit AeroSystems upgraded to Buy from Neutral at Goldman Sachs
03/02/20 SunTrust
Spirit AeroSystems price target lowered to $50 from $66 at SunTrust
ACDVF Air Canada
$0.00 /

+ (+0.00%)

03/11/20 RBC Capital
Air Canada price target lowered to C$46 from C$58 at RBC Capital
11/06/19 JPMorgan
Air Canada upgraded to Overweight from Neutral at JPMorgan
10/08/19 Macquarie
Air Canada initiated with an Outperform rating at Macquarie
08/02/19 JPMorgan
Air Canada downgraded to Neutral from Overweight at JPMorgan
ADDYY Adidas
$0.00 /

+ (+0.00%)

03/05/20 Berenberg
Berenberg highlights Adidas' strong fundamentals in wake of coronavirus
01/28/20 Telsey Advisory
Telsey Advisory upgrades Adidas to Outperform on industry-beating growth
01/28/20 Telsey Advisory
Adidas upgraded to Outperform from Market Perform at Telsey Advisory
01/10/20 Susquehanna
Susquehanna downgrades Foot Locker after holiday checks fall short
TMUS T-Mobile
$86.49 /

+1.51 (+1.78%)

03/09/20 Barclays
T-Mobile price target raised to $94 from $88 at Barclays
03/09/20 Wells Fargo
T-Mobile price target raised to $110 from $98 at Wells Fargo
03/06/20 Bernstein
Dish upgraded to Market Perform from Underperform at Bernstein
03/02/20 BofA
SBA Communications upgraded to Buy from Neutral at BofA
S Sprint
$8.85 /

+0.27 (+3.15%)

EBAY eBay
$34.85 /

-1.18 (-3.28%)

03/03/20 Jefferies
Booking, Expedia, TripAdvisor price targets lowered at Jefferies
02/25/20 RBC Capital
eBay price target lowered to $34 from $37 at RBC Captial
02/21/20 Wells Fargo
Wells Fargo says concerns remain for eBay after StubHub sale
02/10/20 Wells Fargo
Wells Fargo upgrades IntercontinentalExchange to Overweight on eBay selloff
VIR Vir Biotechnology
$33.38 /

+3.43 (+11.45%)

03/04/20 Piper Sandler
Alnylam, Vir expand collaboration for siRNA for COVID-19, says Piper Sandler
02/27/20
Fly Intel: Top five analyst downgrades
02/27/20 Baird
Vir Biotechnology downgraded to Underperform from Neutral at Baird
02/04/20 JPMorgan
Vir Biotechnology downgraded to Neutral after 81% rally at JPMorgan
MNK Mallinckrodt
$3.05 /

+0.855 (+39.04%)

02/25/20 Stifel
Mallinckrodt clearing path for shares to be revalued, says Stifel
01/22/20 Wells Fargo
Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo
09/10/19 Stifel
Mallinckrodt's sale of BioVectra helps alleviate cash pressure, says Stifel
09/09/19 Stifel
Mallinckrodt price target lowered to $8 from $20 at Stifel
MTDR Matador
$1.98 /

-0.39 (-16.46%)

03/10/20 RBC Capital
Matador price target lowered to $13 from $24 at RBC Capital
03/09/20
Fly Intel: Top five analyst downgrades
03/09/20 SunTrust
Matador cut to Hold from Buy at SunTrust
03/09/20 Stifel
Matador downgraded to Hold from Buy at Stifel
CDMO Avid Bioservices
$4.51 /

-1.5 (-24.96%)

12/10/19 First Analysis
Avid Bioservices upgraded to Strong Buy from Outperform at First Analysis
10/16/19 Stephens
Avid Bioservices initiated with an Overweight at Stephens
10/16/19
Craig-Hallum bullish on Avid Bioservices, initiates with a Buy
10/16/19 Craig-Hallum
Avid Bioservices initiated with a Buy at Craig-Hallum
On The Fly
Fly Intel: Wall Street's top stories at midday » 12:43
03/11/20
03/11
12:43
03/11/20
12:43
PEP

PepsiCo

$130.49 /

-3.74 (-2.79%)

, MNST

Monster Beverage

$62.19 /

-3.85 (-5.83%)

, KO

Coca-Cola

$51.90 /

-1.75 (-3.26%)

, DXC

DXC Technology

$16.84 /

+0.43 (+2.62%)

, BA

Boeing

$204.41 /

-26.715 (-11.56%)

, NKE

Nike

$82.92 /

-5.42 (-6.14%)

, ADDYY

Adidas

$0.00 /

+ (+0.00%)

, VIR

Vir Biotechnology

$34.30 /

+4.35 (+14.52%)

, CLDR

Cloudera

$8.25 /

+0.38 (+4.83%)

, MTDR

Matador

$1.94 /

-0.43 (-18.14%)

, CDMO

Avid Bioservices

$4.45 /

-1.56 (-25.96%)

After seeing a bounce…

Open Full Text

ShowHide Related Items >><<
PEP PepsiCo
$130.49 /

-3.74 (-2.79%)

03/11/20 Stifel
Pepsi deal potentially increases odds of Coke acquiring Monster, says Stifel
02/14/20 SunTrust
PepsiCo price target raised to $135 from $125 at SunTrust
02/14/20 Guggenheim
Pepsi guidance may be 'slightly disappointing' compared to Coke, says Guggenheim
01/02/20 Cantor Fitzgerald
Cantor says time for Peltz to call on Aurora to show financial discipline
MNST Monster Beverage
$62.19 /

-3.85 (-5.83%)

02/28/20 Morgan Stanley
Morgan Stanley expects positive stock reaction to Monster Beverage beat
02/23/20 Stifel
Monster Beverage price target raised to $78 from $71 at Stifel
02/03/20 Morgan Stanley
Monster Beverage upgraded to Overweight, price target to $78 at Morgan Stanley
KO Coca-Cola
$51.90 /

-1.75 (-3.26%)

01/31/20 RBC Capital
Coca-Cola price target raised to $66 from $60 at RBC Capital
01/31/20 SunTrust
Coca-Cola price target raised to $65 from $60 at SunTrust
DXC DXC Technology
$16.84 /

+0.43 (+2.62%)

03/12/20 MoffettNathanson
DXC Technology upgraded to Buy from Neutral at MoffettNathanson
03/11/20 Wells Fargo
DXC Technology price target lowered to $18 from $36 at Wells Fargo
03/11/20 Citi
DXC Technology divestiture proceeds higher than expected, says Citi
02/26/20 Morgan Stanley
DXC Technology resumed with an Overweight at Morgan Stanley
BA Boeing
$204.41 /

-26.715 (-11.56%)

03/12/20 Canaccord
Boeing price target lowered to $225 from $340 at Canaccord
03/12/20 JPMorgan
JPMorgan downgrades Boeing to Neutral saying 'it's about the virus now'
03/12/20 JPMorgan
Boeing downgraded to Neutral from Overweight at JPMorgan
03/11/20 Argus
United Airlines downgraded to Hold from Buy at Argus
NKE Nike
$82.92 /

-5.42 (-6.14%)

03/12/20 Piper Sandler
Nike price target lowered to $96 from $103 at Piper Sandler
03/10/20 Barclays
Nike growth will recover once COVID-19 has passed, says Barclays
03/03/20 UBS
Nike price target lowered to $123 from $136 at UBS
02/26/20
Fly Intel: Top five analyst downgrades
ADDYY Adidas
$0.00 /

+ (+0.00%)

03/12/20 Wedbush
Adidas FY20 visibility limited, China impact higher than expected, says Wedbush
03/05/20 Berenberg
Berenberg highlights Adidas' strong fundamentals in wake of coronavirus
01/28/20 Telsey Advisory
Telsey Advisory upgrades Adidas to Outperform on industry-beating growth
VIR Vir Biotechnology
$34.30 /

+4.35 (+14.52%)

03/04/20 Piper Sandler
Alnylam, Vir expand collaboration for siRNA for COVID-19, says Piper Sandler
02/27/20
Fly Intel: Top five analyst downgrades
02/27/20 Baird
Vir Biotechnology downgraded to Underperform from Neutral at Baird
02/04/20 JPMorgan
Vir Biotechnology downgraded to Neutral after 81% rally at JPMorgan
CLDR Cloudera
$8.25 /

+0.38 (+4.83%)

03/11/20 Barclays
Cloudera price target lowered to $10 from $13 at Barclays
01/14/20 Craig-Hallum
New Cloudera CEO brings 'credibility and hybrid vision,' says Craig-Hallum
01/14/20 DA Davidson
New Cloudera CEO announcement suggests a sale more likely, says DA Davidson
12/19/19 Gordon Haskett
Dropbox up 8%, Gordon Haskett says could draw 'special situation interest'
MTDR Matador
$1.94 /

-0.43 (-18.14%)

03/10/20 RBC Capital
Matador price target lowered to $13 from $24 at RBC Capital
03/09/20
Fly Intel: Top five analyst downgrades
03/09/20 SunTrust
Matador cut to Hold from Buy at SunTrust
03/09/20 Stifel
Matador downgraded to Hold from Buy at Stifel
CDMO Avid Bioservices
$4.45 /

-1.56 (-25.96%)

12/10/19 First Analysis
Avid Bioservices upgraded to Strong Buy from Outperform at First Analysis
10/16/19 Stephens
Avid Bioservices initiated with an Overweight at Stephens
10/16/19
Craig-Hallum bullish on Avid Bioservices, initiates with a Buy
10/16/19 Craig-Hallum
Avid Bioservices initiated with a Buy at Craig-Hallum
Hot Stocks
Fly Intel: After Hours Movers » 18:37
03/10/20
03/10
18:37
03/10/20
18:37
HEAR

Turtle Beach

$5.53 /

-0.03 (-0.54%)

, CLDR

Cloudera

$7.87 /

+0.6 (+8.25%)

, APTO

Aptose Biosciences

$7.08 /

-0.27 (-3.67%)

, DXC

DXC Technology

$16.41 /

+0.76 (+4.86%)

, CDMO

Avid Bioservices

$6.01 /

-0.03 (-0.50%)

, CLNE

Clean Energy

$2.01 /

+0.23 (+12.92%)

, VSLR

Vivint Solar

$9.53 /

+0.11 (+1.17%)

, KFY

Korn/Ferry

$31.52 /

+2.18 (+7.43%)

, CTRE

CareTrust REIT

$19.67 /

+0.65 (+3.42%)

, HLT

Hilton

$90.30 /

+4.12 (+4.78%)

UP AFTER EARNINGS: Turtle…

UP AFTER EARNINGS: Turtle Beach (HEAR) up 12.3%... Cloudera (CLDR) up 11.7%... Aptos Biosciences (APTO) up 5.2%. ALSO HIGHER: DXC Technology (DXC) up 16.9% after selling HHS business for $5B. DOWN AFTER EARNINGS: Avid Bioservices (CDMO) down 21.5%... Clean Energy (CLNE) down 14.4%... Vivint Solar (VSLR) down 6.4%... Korn Ferry (KFY) down 2.8%. ALSO LOWER: CareTrust REIT (CTRE) down 6.1% after mixed shelf offering... Hilton (HLT) down 2.4% after withdrawing guidance due to coronavirus. Movers as of 18:15ET.

ShowHide Related Items >><<
HEAR Turtle Beach
$5.53 /

-0.03 (-0.54%)

02/13/20 Lake Street
Turtle Beach price target lowered to $12 from $17 at Lake Street
02/13/20 DA Davidson
Turtle Beach price target lowered to $16 from $20 at DA Davidson
02/13/20 Maxim
Turtle Beach price target lowered to $16 from $22 at Maxim
12/30/19 Maxim
Maxim 'comfortable' with estimates for Turtle Beach after NDR
CLDR Cloudera
$7.87 /

+0.6 (+8.25%)

01/14/20 Craig-Hallum
New Cloudera CEO brings 'credibility and hybrid vision,' says Craig-Hallum
01/14/20 DA Davidson
New Cloudera CEO announcement suggests a sale more likely, says DA Davidson
12/19/19 Gordon Haskett
Dropbox up 8%, Gordon Haskett says could draw 'special situation interest'
12/06/19 JMP Securities
Cloudera price target raised to $15 from $12 at JMP Securities
APTO Aptose Biosciences
$7.08 /

-0.27 (-3.67%)

02/20/20 Maxim
Aptose Biosciences initiated with a Buy at Maxim
02/20/20 Maxim
Aptose Biosciences initiated with a Buy at Maxim
02/06/20 H.C. Wainwright
Aptose Biosciences price target raised to $9 from $6 at H.C. Wainwright
01/09/20 Piper Sandler
Aptose Biosciences initiated with an Overweight at Piper Sandler
DXC DXC Technology
$16.41 /

+0.76 (+4.86%)

02/26/20 Morgan Stanley
DXC Technology resumed with an Overweight at Morgan Stanley
01/09/20 Wells Fargo
Wells Fargo changes three ratings in Commercial IT Services heading into 2020
01/09/20 Wells Fargo
DXC Technology downgraded to Underweight from Equal Weight at Wells Fargo
12/20/19 BMO Capital
DXC Technology price target raised to $43 from $35 at BMO Capital
CDMO Avid Bioservices
$6.01 /

-0.03 (-0.50%)

12/10/19 First Analysis
Avid Bioservices upgraded to Strong Buy from Outperform at First Analysis
10/16/19 Stephens
Avid Bioservices initiated with an Overweight at Stephens
10/16/19
Craig-Hallum bullish on Avid Bioservices, initiates with a Buy
10/16/19 Craig-Hallum
Avid Bioservices initiated with a Buy at Craig-Hallum
CLNE Clean Energy
$2.01 /

+0.23 (+12.92%)

02/03/20 Raymond James
Shorting Clean Energy here seems risky, says Raymond James
02/03/20 Raymond James
Clean Energy upgraded to Market Perform from Underperform at Raymond James
12/26/19 Raymond James
CA electric truck mandate a headwind for Clean Energy, says Raymond James
05/22/19 Craig-Hallum
UPS deal validates Clean Energy as dominant RNG provider, says Craig-Hallum
VSLR Vivint Solar
$9.53 /

+0.11 (+1.17%)

01/30/20 Credit Suisse
Tesla signals strong residential solar growth, says Credit Suisse
09/30/19 Citi
Vivint Solar selloff on short report overdone, says Citi
08/20/19
Fly Intel: Top five analyst initiations
08/20/19
KeyBanc bullish on Sunnova Energy, initiates with an Overweight
KFY Korn/Ferry
$31.52 /

+2.18 (+7.43%)

06/21/19 SunTrust
Korn/Ferry price target lowered to $58 from $63 at SunTrust
CTRE CareTrust REIT
$19.67 /

+0.65 (+3.42%)

02/28/20 Berenberg
CareTrust REIT downgraded to Hold from Buy at Berenberg
02/21/20 Stifel
CareTrust REIT reduced guidance brings buying opportunity, says Stifel
01/07/20 Raymond James
Healthcare REIT sector downgraded to Market Weight at Raymond James
01/07/20 BMO Capital
CareTrust REIT downgraded to Market Perform from Outperform at BMO Capital
HLT Hilton
$90.30 /

+4.12 (+4.78%)

03/09/20 Raymond James
Hilton price target lowered to $110 from $122 at Raymond James
03/09/20 Wells Fargo
Hilton price target lowered to $92 from $114 at Wells Fargo
02/12/20 SunTrust
Hilton price target raised to $107 from $99 at SunTrust
02/12/20 Nomura Instinet
Nomura boosts target to $130 on 'once again' top pick Hilton
Earnings
Avid Bioservices reports Q3 EPS (6c), consensus (4c) » 16:12
03/10/20
03/10
16:12
03/10/20
16:12
CDMO

Avid Bioservices

$5.97 /

-0.07 (-1.16%)

Reports Q3 revenue…

Reports Q3 revenue $13.6M, consensus $15.42M. "During the third quarter of 2020, Avid strengthened both its project pipeline and backlog, and the fundamentals of the business remained strong," said Rick Hancock, interim president and chief executive officer of Avid. "However, the company faced production challenges during the period related to a problem with a specific piece of equipment which resulted in the termination of in-process manufacturing runs, and the postponement of several other manufacturing runs scheduled to commence during the third quarter. Though we are now implementing the necessary corrections, the temporary production interruption resulted in lower revenue and profits for the third quarter, and we expect it to also impact revenues and profits for the fourth quarter of fiscal 2020. For this reason, we are adjusting our revenue guidance for fiscal 2020 to $55 - $59 million versus our prior guidance of $64 - $67 million. It is our expectation that this problem will be behind us soon, and as such, we anticipate that the impact will be contained to fiscal 2020.

ShowHide Related Items >><<
CDMO Avid Bioservices
$5.97 /

-0.07 (-1.16%)

12/10/19 First Analysis
Avid Bioservices upgraded to Strong Buy from Outperform at First Analysis
10/16/19 Stephens
Avid Bioservices initiated with an Overweight at Stephens
10/16/19
Craig-Hallum bullish on Avid Bioservices, initiates with a Buy
10/16/19 Craig-Hallum
Avid Bioservices initiated with a Buy at Craig-Hallum
Hot Stocks
Avid Bioservices appoints Timothy Compton as CCO » 08:09
01/08/20
01/08
08:09
01/08/20
08:09
CDMO

Avid Bioservices

$6.92 /

-0.07 (-1.00%)

, CBM

Cambrex

$0.00 /

+ (+0.00%)

Avid Bioservices (CDMO)…

Avid Bioservices (CDMO) announced the appointment of Timothy Compton as chief commercial officer. In his new role, he will be responsible for driving the continued growth of Avid's CDMO business, including the ongoing expansion of the company's commercial and clinical client base. Compton is replacing Tracy Kinjerski, who has left the company to pursue other opportunities. Compton most recently served as senior director of sales and business development for Cambrex Corporation (CBM).

ShowHide Related Items >><<
CDMO Avid Bioservices
$6.92 /

-0.07 (-1.00%)

12/10/19 First Analysis
Avid Bioservices upgraded to Strong Buy from Outperform at First Analysis
10/16/19 Stephens
Avid Bioservices initiated with an Overweight at Stephens
10/16/19
Craig-Hallum bullish on Avid Bioservices, initiates with a Buy
10/16/19 Craig-Hallum
Avid Bioservices initiated with a Buy at Craig-Hallum
CBM Cambrex
$0.00 /

+ (+0.00%)

08/12/19 Craig-Hallum
Cambrex downgraded to Hold from Buy at Craig-Hallum
08/07/19 William Blair
Cambrex downgraded to Market Perform from Outperform at William Blair
05/07/19
Fly Intel: Top five analyst downgrades
05/07/19 First Analysis
Cambrex downgraded to Outperform from Strong Buy at First Analysis

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.